Literature DB >> 31551171

Long-term Remission by Brentuximab Vedotin for Non-mediastinal Gray Zone Lymphoma Refractory to Autologous Stem Cell Transplantation.

Kazutoshi Ebisawa1, Yosuke Masamoto1, Junji Koya1, Arika Shimura1, Aya Shinozaki-Ushiku2, Kazuhiro Toyama1, Kumi Nakazaki1, Mineo Kurokawa3.   

Abstract

Entities:  

Keywords:  CD30 positive lymphoma; Refractory lymphoma; Salvage treatment; Targeted therapy

Year:  2019        PMID: 31551171     DOI: 10.1016/j.clml.2019.08.017

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma Leuk        ISSN: 2152-2669


× No keyword cloud information.
  1 in total

1.  Brentuximab vedotin maintenance after autologous stem cell transplantation for refractory gray zone lymphoma with long-term remission.

Authors:  Toshiki Terao; Junichiro Yuda; Nobuhiko Yamauchi; Yong-Mei Guo; Kaoru Shimada; Masato Sugano; Genichiro Ishii; Yosuke Minami
Journal:  Mol Clin Oncol       Date:  2021-04-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.